Open Philanthropy recommended a grant of $3,550,000 to KU Leuven to support research, led by Lieve Naesens, to optimize drug candidates that inhibit the influenza virus RNA polymerase and may be useful as antiviral drugs.
This grant was funded via Open Philanthropy’s request for proposals through the Pandemic Antiviral Discovery Initiative. It falls within its focus area of scientific research, specifically within its interest in science supporting biosecurity and pandemic preparedness.